132 research outputs found
Pattern of gray matter volumes related to retinal thickness and its association with cognitive function in relapsing–remitting MS
Background Neurodegeneration in multiple sclerosis (MS) may be investigated in
the visual system as optical coherence tomography (OCT) and magnetic resonance
imaging (MRI) allows examining structural integrity in detail. The association
between thickness of retinal layers and focal cortical volumes beyond the
primary visual system has not been thoroughly investigated. Objective To
investigate the association between focal cortical volume and thickness of
retinal layers. Methods Fifty-four patients (relapsing–remitting MS, mean age
40.5 years, mean disease duration 7.6 years, median EDSS 2) underwent OCT and
MRI. The association between focal cortical volume and OCT measurements was
investigated with voxel-based morphometry (VBM). Patterns of association were
determined with Yeo's functional network atlas and the Harvard-Oxford cortical
atlas. We used GEE models with cortical volumes from the FreeSurfer
parcellation to confirm VBM results. Post hoc, we analyzed the association
between OCT, focal cortical volumes, and an extended neuropsychological
assessment in a subgroup of 14 patients. Results Macular retinal nerve fiber
layer (mRNFL) and ganglion cell /inner plexiform layer (GCIPL) showed a robust
association with mainly the insular cortex and the cingulate cortex. VBM
findings were confirmed with FreeSurfer volumes. The post hoc analysis
detected significant correlations between both OCT outcomes and cognition.
Conclusion Besides the primary visual system, OCT outcomes show a correlation
pattern with cortical regions that are known to be important for cognitive
performance, predominantly the insula in both hemispheres. Thus, OCT should be
further investigated as a marker for neurodegeneration in MS
Treatment of progressive multiple sclerosis: what works, what does not, and what is needed.
Disease-modifying drugs have mostly failed as treatments for progressive multiple sclerosis. Management of the disease therefore solely aims to minimise symptoms and, if possible, improve function. The degree to which this approach is based on empirical data derived from studies of progressive disease or whether treatment decisions are based on what is known about relapsing-remitting disease remains unclear. Symptoms rated as important by patients with multiple sclerosis include balance and mobility impairments, weakness, reduced cardiovascular fitness, ataxia, fatigue, bladder dysfunction, spasticity, pain, cognitive deficits, depression, and pseudobulbar affect; a comprehensive literature search shows a notable paucity of studies devoted solely to these symptoms in progressive multiple sclerosis, which translates to few proven therapeutic options in the clinic. A new strategy that can be used in future rehabilitation trials is therefore needed, with the adoption of approaches that look beyond single interventions to concurrent, potentially synergistic, treatments that maximise what remains of neural plasticity in patients with progressive multiple sclerosis
The Molecular Genetic Architecture of Self-Employment
Economic variables such as income, education, and occupation are known to affect mortality and morbidity, such as cardiovascular disease, and have also been shown to be partly heritable. However, very little is known about which genes influence economic variables, although these genes may have both a direct and an indirect effect on health. We report results from the first large-scale collaboration that studies the molecular genetic architecture of an economic variable-entrepreneurship-that was operationalized using self-employment, a widely-available proxy. Our results suggest that common SNPs when considered jointly explain about half of the narrow-sense heritability of self-employment estimated in twin data (σg2/σP2= 25%, h2= 55%). However, a meta-analysis of genome-wide association studies across sixteen studies comprising 50,627 participants did not identify genome-wide significant SNPs. 58 SNPs with p<10-5were tested in a replication sample (n = 3,271), but none replicated. Furthermore, a gene-based test shows that none of the genes that were previously suggested in the literature to influence entrepreneurship reveal significant associations. Finally, SNP-based genetic scores that use results from the meta-analysis capture less than 0.2% of the variance in self-employment in an independent sample (p≥0.039). Our results are consistent with a highly polygenic molecular genetic architecture of self-employment, with many genetic variants of small effect. Although self-employment is a multi-faceted, heavily environmentally influenced, and biologically distal trait, our results are similar to those for other genetically complex and biologically more proximate outcomes, such as height, intelligence, personality, and several diseases
New insights into the genetic etiology of Alzheimer's disease and related dementias
Characterization of the genetic landscape of Alzheimer's disease (AD) and related dementias (ADD) provides a unique opportunity for a better understanding of the associated pathophysiological processes. We performed a two-stage genome-wide association study totaling 111,326 clinically diagnosed/'proxy' AD cases and 677,663 controls. We found 75 risk loci, of which 42 were new at the time of analysis. Pathway enrichment analyses confirmed the involvement of amyloid/tau pathways and highlighted microglia implication. Gene prioritization in the new loci identified 31 genes that were suggestive of new genetically associated processes, including the tumor necrosis factor alpha pathway through the linear ubiquitin chain assembly complex. We also built a new genetic risk score associated with the risk of future AD/dementia or progression from mild cognitive impairment to AD/dementia. The improvement in prediction led to a 1.6- to 1.9-fold increase in AD risk from the lowest to the highest decile, in addition to effects of age and the APOE ε4 allele
Brain connectivity and cognitive processing speed in multiple sclerosis: A systematic review
Background: Processing speed (PS) decline is the most commonly observed cognitive deficit in
people with multiple sclerosis (MS) resulting in a significant impact on quality of life. Despite its
importance, knowledge of the underlying neural substrates is lacking.
Objective: As MS is increasingly recognised as a disconnection syndrome, our aim was to carry out a
systematic literature review to clarify the relationship between PS performance and MRI measures of
structural and functional brain connectivity in people with MS.
Search methods: A literature search was carried out on PubMed and Web of Science that included
publications predating September 2017. Additional articles were added after inspection of the
reference lists of all selected papers.
Data extraction: All selected papers were categorised in three sections according to the MRI
measures investigated, independently or both. Quality assessment was carried out using a
customised set of criteria.
Results: Thirty-two articles met the inclusion criteria and were included in the review. Microstructural
integrity of the anterior corpus callosum and functional connectivity of frontal areas were more
consistently found to correlate with PS performance, though high variability of findings was observed
across studies. Several methodological flaws emerged from the reviewed literature.
Conclusions: Despite the observed trends, no definite conclusions can be drawn on the relationship
between brain connectivity and PS decline in MS given the limitations of the current literature. Future
investigations may benefit from theoretical and methodological advances to clarify how MS-related
brain damage affects patients’ cognition
Heterogeneity in age-related white matter changes
White matter changes occur endemically in routine magnetic resonance imaging (MRI) scans of elderly persons. MRI appearance and histopathological correlates of white matter changes are heterogeneous. Smooth periventricular hyperintensities, including caps around the ventricular horns, periventricular lining and halos are likely to be of non-vascular origin. They relate to a disruption of the ependymal lining with subependymal widening of the extracellular space and have to be differentiated from subcortical and deep white matter abnormalities. For the latter a distinction needs to be made between punctate, early confluent and confluent types. Although punctate white matter lesions often represent widened perivascular spaces without substantial ischemic tissue damage, early confluent and confluent lesions correspond to incomplete ischemic destruction. Punctate abnormalities on MRI show a low tendency for progression, while early confluent and confluent changes progress rapidly. The causative and modifying pathways involved in the occurrence of sporadic age-related white matter changes are still incompletely understood, but recent microarray and genome-wide association approaches increased the notion of pathways that might be considered as targets for therapeutic intervention. The majority of differentially regulated transcripts in white matter lesions encode genes associated with immune function, cell cycle, proteolysis, and ion transport. Genome-wide association studies identified six SNPs mapping to a locus on chromosome 17q25 to be related to white matter lesion load in the general population. We also report first and preliminary data that demonstrate apolipoprotein E (ApoE) immunoreactivity in white matter lesions and support epidemiological findings indicating that ApoE is another factor possibly related to white matter lesion occurrence. Further insights come from modern MRI techniques, such as diffusion tensor and magnetization transfer imaging, as they provide tools for the characterization of normal-appearing brain tissue beyond what can be expected from standard MRI scans. There is a need for additional pre- and postmortem studies in humans, including these new imaging techniques
Genetic contributions to variation in general cognitive function:a meta-analysis of genome-wide association studies in the CHARGE consortium (<i>N</i>=53 949)
General cognitive function is substantially heritable across the human life course from adolescence to old age. We investigated the genetic contribution to variation in this important, health- and well-being-related trait in middle-aged and older adults. We conducted a meta-analysis of genome-wide association studies of 31 cohorts (N=53 949) in which the participants had undertaken multiple, diverse cognitive tests. A general cognitive function phenotype was tested for, and created in each cohort by principal component analysis. We report 13 genome-wide significant single-nucleotide polymorphism (SNP) associations in three genomic regions, 6q16.1, 14q12 and 19q13.32 (best SNP and closest gene, respectively: rs10457441, P=3.93 × 10−9, MIR2113; rs17522122, P=2.55 × 10−8, AKAP6; rs10119, P=5.67 × 10−9, APOE/TOMM40). We report one gene-based significant association with the HMGN1 gene located on chromosome 21 (P=1 × 10−6). These genes have previously been associated with neuropsychiatric phenotypes. Meta-analysis results are consistent with a polygenic model of inheritance. To estimate SNP-based heritability, the genome-wide complex trait analysis procedure was applied to two large cohorts, the Atherosclerosis Risk in Communities Study (N=6617) and the Health and Retirement Study (N=5976). The proportion of phenotypic variation accounted for by all genotyped common SNPs was 29% (s.e.=5%) and 28% (s.e.=7%), respectively. Using polygenic prediction analysis, ~1.2% of the variance in general cognitive function was predicted in the Generation Scotland cohort (N=5487; P=1.5 × 10−17). In hypothesis-driven tests, there was significant association between general cognitive function and four genes previously associated with Alzheimer’s disease: TOMM40, APOE, ABCG1 and MEF2C
- …
